Melis McHenry
Associate Director Regeneron Pharmaceuticals
Melis McHenry, PhD, is the Associate Director of Precision Medicine Companion Diagnostics at Regeneron Pharmaceuticals. She leads the development of companion diagnostics (CDx), crucial tools for optimizing treatment efficacy and personalizing patient care. Dr. McHenry plays a pivotal role in integrating diagnostics with therapeutic processes to advance precision medicine and improve tailored healthcare solutions. Before joining Regeneron, Dr. McHenry gained extensive experience at Roche Diagnostics and Beckman Coulter, where she served as a subject matter expert across various diagnostic divisions.
Seminars
Thursday 26th March 2026
The Role & Implementation of AAV Immunogenicity Assays in Gene Therapy Clinical Trials
2:30 pm
- Importance of detecting pre-existing AAV antibodies to ensure safety and efficacy in gene therapy trials
- Determination of thresholds for AAV immunogenicity assays through pre-clinical and clinical studies
- Implementation of validated AAV cut-offs in patient selection strategies
